Overview
Status
Active
Registry date
2010-05-14
Share capital
5 000,00 PLN
Registered address
Ewangelicka 2/31, 25-354 Kielce, Poland
Electronic delivery address
AE:PL-63440-44119-IIHCV-25
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 105 days for 2021).
- 202515/07/2026
- 202414/07/2025
- 202315/07/2024
- 202228/07/2023
- 202128/10/2022
- 202015/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.88mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 101.42kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 2.74mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.24mMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
Innomed has been an NFZ healthcare provider since 2012. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 13.74k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Provision of medical devices | świętokrzyskie | 1 | USD 0.00 |
Authorized Representatives
Ireneusz Chaiński – President of the Management Board
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ireneusz Chaińskiage 46 | 99 | $1,337.12 | 99% |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-10-29.
32 1750 1110 0000 0000 3892 7779
38 1930 1800 2630 0619 9087 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 5, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $72,691$72,691 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-KielceS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-04-18 | PKD change (Removed: 05.10.Z, 05.20.Z, 08.11.Z, 08.12.Z, 08.91.Z, 08.99.Z, 09.90.Z, 35.12.Z, 35.13.Z, 35.14.Z, 38.11.Z, 38.21.Z, 41.10.Z, 41.20.Z, 43.11.Z, 43.12.Z, 43.13.Z, 43.21.Z, 43.22.Z, 43.29.Z, 46.12.Z, 46.13.Z, 46.18.Z, 46.19.Z, 46.39.Z, 46.46.Z, 46.63.Z, 46.69.Z, 46.71.Z, 46.72.Z, 46.73.Z, 46.77.Z, 46.90.Z, 47.19.Z, 47.30.Z, 47.41.Z, 47.7, 47.99.Z, 49.41.Z, 49.42.Z, 52.10.B, 52.21.Z, 55.10.Z, 56.10.A, 58.19.Z, 62.03.Z, 62.09.Z, 63.11.Z, 64.99.Z, 66.19.Z, 68.10.Z, 68.20.Z, 68.31.Z, 68.32.Z, 70.21.Z, 70.22.Z, 71.12.Z, 71.20.A, 71.20.B, 73.11.Z, 73.20.Z, 74.90.Z, 77.32.Z, 81.10.Z, 82.11.Z, 82.91.Z, 82.92.Z, 82.99.Z, 86.10.Z, 86.90.A, 86.90.B, 86.90.D; Added: 32.50.Z) | |
| 2013-08-09 | PKD change (Added: 63.11.Z, 77.11.Z) | |
| 2012-03-27 | PKD change (Removed: 86.21.Z, 86.22.Z, 86.23.Z, 86.90.C; Added: 05.10.Z, 05.20.Z, 08.11.Z, 08.12.Z, 08.91.Z, 08.99.Z, 09.90.Z, 35.12.Z, 35.13.Z, 35.14.Z, 38.11.Z, 38.21.Z, 41.10.Z, 41.20.Z, 43.11.Z, 43.12.Z, 43.13.Z, 43.21.Z, 43.22.Z, 43.29.Z, 46.12.Z, 46.13.Z, 46.18.Z, 46.19.Z, 46.39.Z, 46.46.Z, 46.63.Z, 46.69.Z, 46.71.Z, 46.72.Z, 46.73.Z, 46.77.Z, 46.90.Z, 47.19.Z, 47.30.Z, 47.41.Z, 47.7, 47.99.Z, 49.41.Z, 49.42.Z, 52.10.B, 52.21.Z, 55.10.Z, 56.10.A, 58.19.Z, 64.99.Z, 66.19.Z, 68.10.Z, 68.20.Z, 71.12.Z, 73.20.Z, 74.90.Z, 77.12.Z, 77.32.Z, 81.10.Z, 82.11.Z) | |
| 2010-05-14 | Entered in the register |
FAQ
The main business activity of Innomed focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on May 14, 2010.
The headquarters is located at: Ewangelicka 2, 25-354 Kielce.
The management board consists of: Ireneusz Chaiński (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $2,875,604, representing an increase of 10.3% compared to 2024.
Yes, the company recorded a net profit of $101,424 in 2025, meaning the company increased its profit by 24.7%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $2,199,480 in 2025, representing 80% of all operating expenses.
Last updated: 2026-07-16